Novo Nordisk A/S

CEO Lars Fruergaard Jorgensen discusses Wegovy

It's been a rocky few months for Novo Nordisk.Prescription data from IQVIA suggests Novo's obesity drug Wegovy is losing ground…

4 days ago

Eli Lilly to release data on weight loss drug retatrutide in 2025

The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14,…

4 days ago

Eli Lilly (LLY) earnings Q4 2024

Eli Lilly on Thursday reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug…

4 days ago